Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications

British Journal of Ophthalmology

Volumn 82, Issue 10, 1998, Pages 1169-1174

  Frennesson, C ^a   Nilsson, S E G ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARGON LASER; ARTICLE; ATROPHY; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DRUSEN; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; LASER SURGERY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0031670081     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.10.1169     Document Type: Article

References (33)

1. Smiddy WE, Fine SL. Prognosis of patients with bilateral macular drusen. Ophthalmology 1984;91:271-7.
2. Bressler SB, Maguire MG, Bressler NM, et al, the Macular Photocoagulation Study Group. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 1990;108:1442-7.
3. Klein R, Klein BEK, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
4. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration: prognosis and risk factors. Ophthalmology 1994;101:1522-8.
5. Sarraf D, Gin T, Brannon A, et al. Long-term drusen study: evaluation of incidence of choroidal neovascular membrane formation. Invest Ophthalmol Vis Sci 1997;38 (suppl 4):s18.
6. Gregor Z, Bird AC, Chisholm IH. Senile disciform macular degeneration in the second eye. Br J Ophthalmol 1977;61: 141-7.
7. Strahlman ER, Fine SL, Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol 1983; 101:1191-3.
8. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neoyascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997;115:741-7.
9. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-14.
10. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch Ophthalmol 1994;112:500-9.
11. Freund KB, Yanuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786-91.
12. Cleasby CW, Nakanishi AS, Morris LJ. Modern problems in ophthalmology. Basle: Karger:1979;20:141-7.
13. Wetzig PC. Photocoagulation of drusen-related macular degeneration: a long-term outcome. Trans Am Ophthalmol Soc 1994;92:299-306.
14. Figueroa MS, Regueras A, Bertrand J. Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina 1994;14:391-6.
15. Frennesson IC, Nilsson SEG. Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy (ARM). A six-month prospective study. Br J Ophthalmol 1995;79:905-9.
16. Frennesson IC, Nilsson SEG. Laser photocoagulation of soft drusen in early age-related maculopathy (ARM). The one-year results of a prospective, randomised trial. Eur J Ophthalmol 1996;6:307-14.
17. Sarks SH, Arnold JJ, Sarks JP, et al. Prophylactic perifoveal laser treatment of soft drusen. Aust NZ J Ophthalmol 1996; 24:15-26.
18. Little HL, Showman JM, Brown BW. A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft drusen. Ophthalmology 1997;104:623-31.
19. Guymer RH, Gross-Jendroska M, Owens SL, et al. Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function. Arch Ophthalmol 1997;115:595-603.
20. Arden GB, Gündüz K, Perry S. Color vision testing with a computer graphics system. Clin Vis Sci 1988;2:303-20.
21. Arden GB, Berninger T, Hogg C, et al. A survey of color discrimination in German ophthalmologists. Changes associated with the use of lasers and operating microscopes. Ophthalmology 1991;98:567-75.
22. Frennesson IC, Nilsson UL, Nilsson SEG. Colour contrast sensitivity in patients with soft drusen, an early stage of ARM. Doc Ophthalmol 1995;90:377-86.
23. Gass JMD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 1973;90:206-17.
24. Siegelman J. Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology 1991;98: 1379-83.
25. The Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Ophthalmology 1998;105:11-23.
26. Miller H, Miller B, Ishibashi T, et al. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci 1990;31:899-908.
27. Marshall J. Interactions between sensory cells, glial cells and the retinal pigment epithelium and their response to photocoagulation. Dev Ophthalmol 1981;2:308-17.
28. Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol 1984;102:126-35.
29. Della NG, Wilson DJ, Klein ML. Clinical and pathologic effects of grid macular laser in aged primate eyes containing drusen. Invest Ophihalmol Vis Sci 1997;38 (suppl 4):s18.
30. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigment epithelial cells. J Cell Sci 1994;107:2459-69.
31. Yamamoto C, Ogata N, Yi X, et al. Immunolocalization of basic fibroblast growth factor during wound repair in rat retina after laser photocoagulation. Graefes Arch Clin Exp Ophthalmol 1996;11:695-702.
32. Duvall J, Tso MOM. Cellular mechanisms of resolution of drusen after laser photocoagulation: an experimental study. Arch Ophthalmol 1985;103:694-703.
33. Guymer RH, Hageman GS, Bird AC. Choroidal endothelial cell processes into Bruch's membrane. Invest Ophthalmol Vis Sci 1997;38 (suppl 4):s353.